0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Antibody (scFv) Production Services Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-29G18810
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Antibody scFv Production Services Market Research Report 2025
BUY CHAPTERS

Global Recombinant Antibody (scFv) Production Services Market Research Report 2025

Code: QYRE-Auto-29G18810
Report
March 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Antibody (scFv) Production Services Market Size

The global market for Recombinant Antibody (scFv) Production Services was valued at US$ 316 million in the year 2024 and is projected to reach a revised size of US$ 440 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Recombinant Antibody (scFv) Production Services Market

Recombinant Antibody (scFv) Production Services Market

The Recombinant Antibody (scFv) Production Service produces recombinant single-chain variable fragment (scFv) antibodies. scFvs are smaller antibody fragments compared to full-length IgG and can be used in a variety of applications such as diagnostics, therapeutics, and as research tools due to their small size and high specificity.
North American market for Recombinant Antibody (scFv) Production Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Antibody (scFv) Production Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Recombinant Antibody (scFv) Production Services in Drug Development and Treatment is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Recombinant Antibody (scFv) Production Services include Syd Labs, Creative Biolabs, Wuxi Biologics, Leinco, ProteoGenix, GenScript, Abvigen, Curia, Selvita, Profacgen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Antibody (scFv) Production Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Antibody (scFv) Production Services.
The Recombinant Antibody (scFv) Production Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Antibody (scFv) Production Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Antibody (scFv) Production Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Recombinant Antibody (scFv) Production Services Market Report

Report Metric Details
Report Name Recombinant Antibody (scFv) Production Services Market
Accounted market size in year US$ 316 million
Forecasted market size in 2031 US$ 440 million
CAGR 4.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Drug Development and Treatment
  • Diagnosis and Testing
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Syd Labs, Creative Biolabs, Wuxi Biologics, Leinco, ProteoGenix, GenScript, Abvigen, Curia, Selvita, Profacgen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Recombinant Antibody (scFv) Production Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant Antibody (scFv) Production Services Market growing?

Ans: The Recombinant Antibody (scFv) Production Services Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Recombinant Antibody (scFv) Production Services Market size in 2031?

Ans: The Recombinant Antibody (scFv) Production Services Market size in 2031 will be US$ 440 million.

Who are the main players in the Recombinant Antibody (scFv) Production Services Market report?

Ans: The main players in the Recombinant Antibody (scFv) Production Services Market are Syd Labs, Creative Biolabs, Wuxi Biologics, Leinco, ProteoGenix, GenScript, Abvigen, Curia, Selvita, Profacgen

What are the Application segmentation covered in the Recombinant Antibody (scFv) Production Services Market report?

Ans: The Applications covered in the Recombinant Antibody (scFv) Production Services Market report are Drug Development and Treatment, Diagnosis and Testing, Other

What are the Type segmentation covered in the Recombinant Antibody (scFv) Production Services Market report?

Ans: The Types covered in the Recombinant Antibody (scFv) Production Services Market report are Production Based on Mammalian Cells, Production Based on Bacterial Expression Systems, Production Based on Yeast Expression Systems, Other

Recommended Reports

Recombinant Protein Services

Antibody Technologies

Bio-Manufacturing Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Antibody (scFv) Production Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Production Based on Mammalian Cells
1.2.3 Production Based on Bacterial Expression Systems
1.2.4 Production Based on Yeast Expression Systems
1.2.5 Other
1.3 Market by Application
1.3.1 Global Recombinant Antibody (scFv) Production Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Development and Treatment
1.3.3 Diagnosis and Testing
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Antibody (scFv) Production Services Market Perspective (2020-2031)
2.2 Global Recombinant Antibody (scFv) Production Services Growth Trends by Region
2.2.1 Global Recombinant Antibody (scFv) Production Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Antibody (scFv) Production Services Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Antibody (scFv) Production Services Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Antibody (scFv) Production Services Market Dynamics
2.3.1 Recombinant Antibody (scFv) Production Services Industry Trends
2.3.2 Recombinant Antibody (scFv) Production Services Market Drivers
2.3.3 Recombinant Antibody (scFv) Production Services Market Challenges
2.3.4 Recombinant Antibody (scFv) Production Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Antibody (scFv) Production Services Players by Revenue
3.1.1 Global Top Recombinant Antibody (scFv) Production Services Players by Revenue (2020-2025)
3.1.2 Global Recombinant Antibody (scFv) Production Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Recombinant Antibody (scFv) Production Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Antibody (scFv) Production Services Revenue
3.4 Global Recombinant Antibody (scFv) Production Services Market Concentration Ratio
3.4.1 Global Recombinant Antibody (scFv) Production Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody (scFv) Production Services Revenue in 2024
3.5 Global Key Players of Recombinant Antibody (scFv) Production Services Head office and Area Served
3.6 Global Key Players of Recombinant Antibody (scFv) Production Services, Product and Application
3.7 Global Key Players of Recombinant Antibody (scFv) Production Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Antibody (scFv) Production Services Breakdown Data by Type
4.1 Global Recombinant Antibody (scFv) Production Services Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Antibody (scFv) Production Services Forecasted Market Size by Type (2026-2031)
5 Recombinant Antibody (scFv) Production Services Breakdown Data by Application
5.1 Global Recombinant Antibody (scFv) Production Services Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Antibody (scFv) Production Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Antibody (scFv) Production Services Market Size (2020-2031)
6.2 North America Recombinant Antibody (scFv) Production Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Antibody (scFv) Production Services Market Size by Country (2020-2025)
6.4 North America Recombinant Antibody (scFv) Production Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Antibody (scFv) Production Services Market Size (2020-2031)
7.2 Europe Recombinant Antibody (scFv) Production Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Antibody (scFv) Production Services Market Size by Country (2020-2025)
7.4 Europe Recombinant Antibody (scFv) Production Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody (scFv) Production Services Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Antibody (scFv) Production Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Antibody (scFv) Production Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Antibody (scFv) Production Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Antibody (scFv) Production Services Market Size (2020-2031)
9.2 Latin America Recombinant Antibody (scFv) Production Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Antibody (scFv) Production Services Market Size by Country (2020-2025)
9.4 Latin America Recombinant Antibody (scFv) Production Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody (scFv) Production Services Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Antibody (scFv) Production Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Antibody (scFv) Production Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Antibody (scFv) Production Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Syd Labs
11.1.1 Syd Labs Company Details
11.1.2 Syd Labs Business Overview
11.1.3 Syd Labs Recombinant Antibody (scFv) Production Services Introduction
11.1.4 Syd Labs Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025)
11.1.5 Syd Labs Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Recombinant Antibody (scFv) Production Services Introduction
11.2.4 Creative Biolabs Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 Wuxi Biologics
11.3.1 Wuxi Biologics Company Details
11.3.2 Wuxi Biologics Business Overview
11.3.3 Wuxi Biologics Recombinant Antibody (scFv) Production Services Introduction
11.3.4 Wuxi Biologics Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025)
11.3.5 Wuxi Biologics Recent Development
11.4 Leinco
11.4.1 Leinco Company Details
11.4.2 Leinco Business Overview
11.4.3 Leinco Recombinant Antibody (scFv) Production Services Introduction
11.4.4 Leinco Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025)
11.4.5 Leinco Recent Development
11.5 ProteoGenix
11.5.1 ProteoGenix Company Details
11.5.2 ProteoGenix Business Overview
11.5.3 ProteoGenix Recombinant Antibody (scFv) Production Services Introduction
11.5.4 ProteoGenix Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025)
11.5.5 ProteoGenix Recent Development
11.6 GenScript
11.6.1 GenScript Company Details
11.6.2 GenScript Business Overview
11.6.3 GenScript Recombinant Antibody (scFv) Production Services Introduction
11.6.4 GenScript Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025)
11.6.5 GenScript Recent Development
11.7 Abvigen
11.7.1 Abvigen Company Details
11.7.2 Abvigen Business Overview
11.7.3 Abvigen Recombinant Antibody (scFv) Production Services Introduction
11.7.4 Abvigen Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025)
11.7.5 Abvigen Recent Development
11.8 Curia
11.8.1 Curia Company Details
11.8.2 Curia Business Overview
11.8.3 Curia Recombinant Antibody (scFv) Production Services Introduction
11.8.4 Curia Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025)
11.8.5 Curia Recent Development
11.9 Selvita
11.9.1 Selvita Company Details
11.9.2 Selvita Business Overview
11.9.3 Selvita Recombinant Antibody (scFv) Production Services Introduction
11.9.4 Selvita Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025)
11.9.5 Selvita Recent Development
11.10 Profacgen
11.10.1 Profacgen Company Details
11.10.2 Profacgen Business Overview
11.10.3 Profacgen Recombinant Antibody (scFv) Production Services Introduction
11.10.4 Profacgen Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025)
11.10.5 Profacgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Recombinant Antibody (scFv) Production Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Production Based on Mammalian Cells
 Table 3. Key Players of Production Based on Bacterial Expression Systems
 Table 4. Key Players of Production Based on Yeast Expression Systems
 Table 5. Key Players of Other
 Table 6. Global Recombinant Antibody (scFv) Production Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Recombinant Antibody (scFv) Production Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Recombinant Antibody (scFv) Production Services Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Recombinant Antibody (scFv) Production Services Market Share by Region (2020-2025)
 Table 10. Global Recombinant Antibody (scFv) Production Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Recombinant Antibody (scFv) Production Services Market Share by Region (2026-2031)
 Table 12. Recombinant Antibody (scFv) Production Services Market Trends
 Table 13. Recombinant Antibody (scFv) Production Services Market Drivers
 Table 14. Recombinant Antibody (scFv) Production Services Market Challenges
 Table 15. Recombinant Antibody (scFv) Production Services Market Restraints
 Table 16. Global Recombinant Antibody (scFv) Production Services Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Recombinant Antibody (scFv) Production Services Market Share by Players (2020-2025)
 Table 18. Global Top Recombinant Antibody (scFv) Production Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody (scFv) Production Services as of 2024)
 Table 19. Ranking of Global Top Recombinant Antibody (scFv) Production Services Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Recombinant Antibody (scFv) Production Services Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Recombinant Antibody (scFv) Production Services, Headquarters and Area Served
 Table 22. Global Key Players of Recombinant Antibody (scFv) Production Services, Product and Application
 Table 23. Global Key Players of Recombinant Antibody (scFv) Production Services, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Recombinant Antibody (scFv) Production Services Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Recombinant Antibody (scFv) Production Services Revenue Market Share by Type (2020-2025)
 Table 27. Global Recombinant Antibody (scFv) Production Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Recombinant Antibody (scFv) Production Services Revenue Market Share by Type (2026-2031)
 Table 29. Global Recombinant Antibody (scFv) Production Services Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Recombinant Antibody (scFv) Production Services Revenue Market Share by Application (2020-2025)
 Table 31. Global Recombinant Antibody (scFv) Production Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Recombinant Antibody (scFv) Production Services Revenue Market Share by Application (2026-2031)
 Table 33. North America Recombinant Antibody (scFv) Production Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Recombinant Antibody (scFv) Production Services Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Recombinant Antibody (scFv) Production Services Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Recombinant Antibody (scFv) Production Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Recombinant Antibody (scFv) Production Services Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Recombinant Antibody (scFv) Production Services Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Recombinant Antibody (scFv) Production Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Recombinant Antibody (scFv) Production Services Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Recombinant Antibody (scFv) Production Services Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Recombinant Antibody (scFv) Production Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Recombinant Antibody (scFv) Production Services Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Antibody (scFv) Production Services Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Recombinant Antibody (scFv) Production Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Recombinant Antibody (scFv) Production Services Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Recombinant Antibody (scFv) Production Services Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Syd Labs Company Details
 Table 49. Syd Labs Business Overview
 Table 50. Syd Labs Recombinant Antibody (scFv) Production Services Product
 Table 51. Syd Labs Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025) & (US$ Million)
 Table 52. Syd Labs Recent Development
 Table 53. Creative Biolabs Company Details
 Table 54. Creative Biolabs Business Overview
 Table 55. Creative Biolabs Recombinant Antibody (scFv) Production Services Product
 Table 56. Creative Biolabs Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025) & (US$ Million)
 Table 57. Creative Biolabs Recent Development
 Table 58. Wuxi Biologics Company Details
 Table 59. Wuxi Biologics Business Overview
 Table 60. Wuxi Biologics Recombinant Antibody (scFv) Production Services Product
 Table 61. Wuxi Biologics Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025) & (US$ Million)
 Table 62. Wuxi Biologics Recent Development
 Table 63. Leinco Company Details
 Table 64. Leinco Business Overview
 Table 65. Leinco Recombinant Antibody (scFv) Production Services Product
 Table 66. Leinco Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025) & (US$ Million)
 Table 67. Leinco Recent Development
 Table 68. ProteoGenix Company Details
 Table 69. ProteoGenix Business Overview
 Table 70. ProteoGenix Recombinant Antibody (scFv) Production Services Product
 Table 71. ProteoGenix Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025) & (US$ Million)
 Table 72. ProteoGenix Recent Development
 Table 73. GenScript Company Details
 Table 74. GenScript Business Overview
 Table 75. GenScript Recombinant Antibody (scFv) Production Services Product
 Table 76. GenScript Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025) & (US$ Million)
 Table 77. GenScript Recent Development
 Table 78. Abvigen Company Details
 Table 79. Abvigen Business Overview
 Table 80. Abvigen Recombinant Antibody (scFv) Production Services Product
 Table 81. Abvigen Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025) & (US$ Million)
 Table 82. Abvigen Recent Development
 Table 83. Curia Company Details
 Table 84. Curia Business Overview
 Table 85. Curia Recombinant Antibody (scFv) Production Services Product
 Table 86. Curia Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025) & (US$ Million)
 Table 87. Curia Recent Development
 Table 88. Selvita Company Details
 Table 89. Selvita Business Overview
 Table 90. Selvita Recombinant Antibody (scFv) Production Services Product
 Table 91. Selvita Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025) & (US$ Million)
 Table 92. Selvita Recent Development
 Table 93. Profacgen Company Details
 Table 94. Profacgen Business Overview
 Table 95. Profacgen Recombinant Antibody (scFv) Production Services Product
 Table 96. Profacgen Revenue in Recombinant Antibody (scFv) Production Services Business (2020-2025) & (US$ Million)
 Table 97. Profacgen Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Recombinant Antibody (scFv) Production Services Picture
 Figure 2. Global Recombinant Antibody (scFv) Production Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Antibody (scFv) Production Services Market Share by Type: 2024 VS 2031
 Figure 4. Production Based on Mammalian Cells Features
 Figure 5. Production Based on Bacterial Expression Systems Features
 Figure 6. Production Based on Yeast Expression Systems Features
 Figure 7. Other Features
 Figure 8. Global Recombinant Antibody (scFv) Production Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Recombinant Antibody (scFv) Production Services Market Share by Application: 2024 VS 2031
 Figure 10. Drug Development and Treatment Case Studies
 Figure 11. Diagnosis and Testing Case Studies
 Figure 12. Other Case Studies
 Figure 13. Recombinant Antibody (scFv) Production Services Report Years Considered
 Figure 14. Global Recombinant Antibody (scFv) Production Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Recombinant Antibody (scFv) Production Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Recombinant Antibody (scFv) Production Services Market Share by Region: 2024 VS 2031
 Figure 17. Global Recombinant Antibody (scFv) Production Services Market Share by Players in 2024
 Figure 18. Global Recombinant Antibody (scFv) Production Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Recombinant Antibody (scFv) Production Services Revenue in 2024
 Figure 20. North America Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Recombinant Antibody (scFv) Production Services Market Share by Country (2020-2031)
 Figure 22. United States Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Antibody (scFv) Production Services Market Share by Country (2020-2031)
 Figure 26. Germany Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Recombinant Antibody (scFv) Production Services Market Share by Region (2020-2031)
 Figure 34. China Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Recombinant Antibody (scFv) Production Services Market Share by Country (2020-2031)
 Figure 42. Mexico Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Recombinant Antibody (scFv) Production Services Market Share by Country (2020-2031)
 Figure 46. Turkey Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Recombinant Antibody (scFv) Production Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Syd Labs Revenue Growth Rate in Recombinant Antibody (scFv) Production Services Business (2020-2025)
 Figure 50. Creative Biolabs Revenue Growth Rate in Recombinant Antibody (scFv) Production Services Business (2020-2025)
 Figure 51. Wuxi Biologics Revenue Growth Rate in Recombinant Antibody (scFv) Production Services Business (2020-2025)
 Figure 52. Leinco Revenue Growth Rate in Recombinant Antibody (scFv) Production Services Business (2020-2025)
 Figure 53. ProteoGenix Revenue Growth Rate in Recombinant Antibody (scFv) Production Services Business (2020-2025)
 Figure 54. GenScript Revenue Growth Rate in Recombinant Antibody (scFv) Production Services Business (2020-2025)
 Figure 55. Abvigen Revenue Growth Rate in Recombinant Antibody (scFv) Production Services Business (2020-2025)
 Figure 56. Curia Revenue Growth Rate in Recombinant Antibody (scFv) Production Services Business (2020-2025)
 Figure 57. Selvita Revenue Growth Rate in Recombinant Antibody (scFv) Production Services Business (2020-2025)
 Figure 58. Profacgen Revenue Growth Rate in Recombinant Antibody (scFv) Production Services Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart